News NIIMBL Releases the First Industry-wide Biomanufacturing Readiness Level Framework for Biologics NEWARK, Del., Sept. 29, 2022 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals…Super UserOctober 3, 2022
News SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy GAITHERSBURG, Maryland and VANCOUVER, British Columbia – September 29, 2022 – miRecule, Inc., an innovator of…Super UserOctober 3, 2022
News Administrator Guzman Applauds Passage of Small Business Innovation Research (SBIR) Program Reauthorization, Committing to Scientific and Technology Innovation WASHINGTON – Administrator Isabella Casillas Guzman, head of the U.S. Small Business Administration and voice…Super UserSeptember 30, 2022
News Commerce secretary, local experts project how recession would affect life sciences Some economists say yes — and predict it's going to be bad — while others…Super UserSeptember 29, 2022
News Additional Information on New NIH MedTech Program: Incubator hubs will provide subawards to technology innovation teams and aim to accelerate medical devices to treat, diagnose nervous system disorders – The LaunchPort Newswise — The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs…Super UserSeptember 29, 2022
News MaxCyte Signs Strategic Platform License with Vertex Pharmaceuticals to Advance CRISPR/Cas9-based Gene-editing Program Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell…Super UserSeptember 29, 2022
News Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight Twenty-four week interim analysis on approximately 160 subjects planned for Q1 2023 September 28, 2022…Super UserSeptember 29, 2022
News Emmes Acquires Clinical Edge The Company's Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach ROCKVILLE, Md., Sept. 28,…Super UserSeptember 29, 2022
News Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today…Super UserSeptember 29, 2022
News President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H) – The White House Today, President Joe Biden announced his intent to appoint Dr. Renee Wegrzyn as the first…Super UserSeptember 29, 2022